Encyclopedia

hypertrophy

Also found in: Dictionary, Medical, Wikipedia.

hypertrophy

enlargement of an organ or part resulting from an increase in the size of the cells
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005

hypertrophy

[hī′pər·trə·fē]
(pathology)
Increase in cell size causing an increase in the size of an organ or tissue.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
The following article is from The Great Soviet Encyclopedia (1979). It might be outdated or ideologically biased.

Hypertrophy

 

an increase in the volume of a body organ or of any of its parts.

Hypertrophy in man (or in animals) may occur either as the result of the enlargement of the individual component elements of an organ (cells and tissues) or as the result of an increase in their quantity (hyperplasia). True hypertrophy and false hypertrophy are distinguished. The former includes enlargement in volume or mass of specific elements as the result of an increased functional load (so-called functional, or compensatory, hypertrophy) or disruption of the regulatory influences of the nervous and endocrine systems. Functional hypertrophy may appear in healthy persons who are occupied with physical labor, such as in athletes (“physiologic hypertrophy” of the muscles). It may also appear upon affection of a part of any organ, such as after heart failure (compensatory hypertrophy) or after the destruction of a paired organ, such as a kidney (vicarious hypertrophy). Compensation for the impaired functions occurs in all instances of functional hypertrophy. Examples of hypertrophy occurring as a result of the disruption of neuroendocrine influences include acromegaly and gynecomastia; in these cases the hypertrophy has no compensatory significance but is accompanied by considerable disturbances of function. False hypertrophy refers to enlargement of the organ as the result of excessive growth of the interstitial, most often the adipose, tissue in response to atrophy of the parenchyma (the functional tissue). Function of the organ in such cases is usually decreased.

L. L. SHIMKEVICH

Hypertrophy of plant organs is the result of an increase in the size of their cells. The hypertrophy may be the effect of increased synthesis of the substances of the cell membrane or cytoplasm, deposits of reserve compounds, or the development of polynucleosis or polyploidy. The causes of hypertrophy include disruption of the synthesis and metabolism of phenol compounds, amino acids, proteins, carbohydrates, and fats, as well as deficiency of trace elements. The condition may also be caused by viruses, bacteria, fungi, invertebrates, and plant parasites. It may accompany many mutations, grafts, and the effects on the plant of ionizing radiation or ultrasound. Hypertrophy is usually interconnected with hyperplasia and disruptions of tissue differentiation in the organs. In many instances (for example, when there is development of tumors or galls) hypertrophy follows cell division; after mechanical injury and physical or chemical effects, however, it is often primary. Hypertrophy is observed in higher as well as in lower plants.

E. I. SLEPIAN

The Great Soviet Encyclopedia, 3rd Edition (1970-1979). © 2010 The Gale Group, Inc. All rights reserved.
Mentioned in
References in periodicals archive
Cardiomyocyte hypertrophy induced by the TLR 2/4 agonists was measured by calculating cardiomyocyte surface area.
LV hypertrophy itself is not the focus of treatment: The underlying disease is addressed.
Moreover, in cardiac hypertrophy NT-proBNP is considered a discerning marker.
In an article published by Liu and Zhu (4), it was demonstrated that the liver underwent hypertrophy by about 10%-46% within 2-8 weeks after PVE.
The results showed that physical training was effective in promoting muscle hypertrophy in all trained groups in relation to group C.
In cardiomyocytes, the activity of cell cycle controls cell proliferation, which plays an important role in cardiac hypertrophy.[14] These findings intrigued us to investigate the role of miR-24 in cardiac hypertrophy and its potential targets.
Results: The mean +- SD of height of proliferative and hypertrophy zones of control group G1 animals was found to be 31.5 +- 4.1um and 43 +- 2.6um, respectively.
Conclusion: Allopurinol was found to be more effective than febuxostatin reducing the left ventricular mass and left ventricular hypertrophy independent of blood pressure.
Among the adults with adenoid hypertrophy, 95 (63.76%) were males.
Among all patients, the prevalence was 67% for NVC, 76% for septal deviation, and 72% for inferior turbinate hypertrophy The prevalence in the subgroup of patients with severe/extreme nasal obstruction for NVC, septal deviation, and inferior turbinate hypertrophy was 73,80, and 77%, respectively.
Left ventricular hypertrophy (LVH) detected either by electrocardiography or echocardiography, has long been recognised as a powerful predictor of serious cardiovascular sequelae.
We observed drastic increase in the frequency as well the intensity of the signal spikes in the PE treated cardiomyocytes grown on keratin coated surfaces which is characteristic of cardiomyocyte hypertrophy.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.